文献速递免疫规划传染病防控与疫情报告

芬兰轮状病毒疫苗接种成功:一项基于登记数据衡量超越总体效果的影响研究

Success ofrotavirus vaccination in Finland, a register based study measuring impact beyond overall effectiveness.
PubMed 文献 · Vaccine · 2020-04-09

芬兰2009年将轮状病毒疫苗纳入国家免疫规划,本研究基于登记数据库对超过20万名0.5-2岁儿童进行回顾性分析,比较疫苗接种前(2002、2003年出生)与接种后(2014、2015年出生)队列的急性胃肠炎住院和门诊发病率。结果显示2014、2015年出生儿童轮状病毒胃肠炎住院病例减少96%,全因急性胃肠炎住院减少78%,直接疫苗效果分别为96%和53%,间接保护分别为67%和56%。结论认为尽管各病种总体发病率下降,轮状病毒仍在季节性流行且发病年龄略有后移,需持续监测。

要点

  • 2014、2015年出生儿童轮状病毒胃肠炎住院较接种前减少96%,全因急性胃肠炎住院减少78%。
  • 轮状病毒胃肠炎和全因急性胃肠炎的直接疫苗效果分别为96%和53%。
  • 轮状病毒胃肠炎和全因急性胃肠炎的间接保护分别为67%和56%。

核心结论

  • 尽管所研究的每种疾病总体发病率均下降,轮状病毒仍在季节性流行,且疾病略有向较大年龄组转移。
  • 结合轮状病毒基因型分布的变化,结果提示仍有必要持续监测。

研究设计与样本

  • 回顾性分析登记数据库数据,纳入超过20万名0.5-2岁儿童。
  • 比较轮状病毒疫苗可用前出生(2002、2003年)与轮状病毒疫苗接种规划实施后出生(2014、2015年)的儿童,随访急性感染性胃肠炎发作。
  • 计算医院门诊和住院发作的发病率,并使用个体疫苗接种记录估计总体、总、直接和间接疫苗效果(VE%)。

主要发现

  • 2014和2015年出生儿童中,住院轮状病毒胃肠炎发作减少96%,住院全因急性胃肠炎发作减少78%,构成总体疫苗效果。
  • 轮状病毒胃肠炎和全因急性胃肠炎的直接效果分别为96%和53%。
  • 间接保护(群体效应)对住院轮状病毒胃肠炎估计为67%,对住院全因急性胃肠炎为56%。
  • 与疫苗接种前时代相比,接种儿童获得的总疫苗效果对住院轮状病毒胃肠炎为99%,对住院全因急性胃肠炎为79%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Even with vaccines available since 2006, rotavirus continues to be a major cause of acute gastroenteritis globally in children under 5 years old. Finland introduced the rotavirus vaccine to its national vaccination programme in 2009. Since then hospitalizations due to gastroenteritis caused by rotavirus (RVGE) and of all causes (AGE) have been reduced significantly in young children. METHODS: We performed a retrospective analysis of data from register databases consisting of over 200 000 children aged 0.5-2 years. Children born before rotavirus vaccines were available (2002, 2003) and after the implementation of rotavirus vaccination programme (2014, 2015) were followed for episodes of acute infectious gastroenteritis. We calculated the incidences of hospital outpatient and inpatient episodes and used individual vaccination records to estimate the overall, total, direct and indirect vaccine effect (VE %). RESULTS: Among children born in 2014 and 2015, there was a 96% reduction in inpatient RVGE episodes and a 78% reduction in episodes of inpatient AGE compared to the pre-vaccination era, comprising the overall VE. Direct effectiveness was 96% and 53% for RVGE and AGE respectively. Herd effect i.e. indirect protection was estimated to be 67% against inpatient RVGE and 56% against inpatient AGE. Protection acquired by the vaccinated children when compared to pre vaccination era i.e. the total VE was 99% for inpatient RVGE and 79% for inpatient AGE. CONCLUSIONS: Although overall incidences for every disease type studied were reduced, rotavirus is still circulating with seasonality and there is a slight shift of disease towards the older age groups. Together with changes observed in the distribution of rotavirus genotypes, our results indicate that continuous monitoring is still necessary.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Solastie A, Leino T, Ollgren J, et al. Success ofrotavirus vaccination in Finland, a register based study measuring impact beyond overall effectiveness. Vaccine. 2020. PMID: 32280041. doi:10.1016/j.vaccine.2020.03.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。